• SPX
  • 6090.27
  • 0.25 %
  • 15.1602
  • DJI
  • 44642.52
  • -0.28 %
  • -123.1914
  • N225
  • 39091.17
  • -0.77 %
  • -304.4297
  • FTSE
  • 8308.61
  • -0.49 %
  • -40.7695
  • IXIC
  • 19859.773
  • 0.81 %
  • 159.0508
Mersana Therapeutics, Inc. (MRSN) Insider Traders

Mersana Therapeutics, Inc. (MRSN) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price

$2.52

$0.2

(8.62%)

Day's range
$2.3
Day's range
$2.55
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    0
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    8
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $0
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $390,684

Mersana Therapeutics, Inc. Insider Transactions

Mersana Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
DeSchuytner Brian

SVP, COO & CFO

Sell 5,598 @ $1.96 $10,972 94,824 10/03/2024 10/07/2024
Carvajal Alejandra

SVP, Chief Legal Officer

Sell 5,598 @ $1.96 $10,972 63,716 10/03/2024 10/07/2024
Bala Mohan

SVP, Chief Development Officer

Sell 5,598 @ $1.96 $10,972 50,365 10/03/2024 10/07/2024
Mandelia Ashish

VP, CAO

Sell 3,361 @ $1.96 $6,588 47,757 10/03/2024 10/07/2024
Lowinger Timothy B

SVP, Chief Sci.&Tech. Officer

Sell 5,598 @ $1.96 $10,972 235,642 10/03/2024 10/07/2024
DeSchuytner Brian

SVP, COO & CFO

Sell 8,089 @ $2.00 $16,178 100,422 10/02/2024 10/07/2024
Carvajal Alejandra

SVP, Chief Legal Officer

Sell 8,089 @ $2.00 $16,178 69,314 10/02/2024 10/07/2024
Bala Mohan

SVP, Chief Development Officer

Sell 8,089 @ $2.00 $16,178 55,963 10/02/2024 10/07/2024
Mandelia Ashish

VP, CAO

Sell 4,855 @ $2.00 $9,710 51,118 10/02/2024 10/07/2024
Lowinger Timothy B

SVP, Chief Sci.&Tech. Officer

Sell 8,089 @ $2.00 $16,178 241,240 10/02/2024 10/07/2024
Sell 50,423 @ $1.76 $88,744 116,327 09/12/2024 09/13/2024
Protopapas Anna

Director

Sell 29,399 @ $2.71 $79,671 125,153 01/16/2024 01/17/2024
MISRA TUSHAR

SVP, Chief Manuf. Officer

Sell 3,357 @ $2.71 $9,097 17,966 01/16/2024 01/17/2024
Mandelia Ashish

VP, CAO

Sell 5,025 @ $2.71 $13,618 23,328 01/16/2024 01/17/2024
Lowinger Timothy B

SVP, Chief Sci.&Tech. Officer

Sell 10,409 @ $2.71 $28,208 199,329 01/16/2024 01/17/2024
Carvajal Alejandra

SVP, Chief Legal Officer

Sell 4,381 @ $2.71 $11,873 27,403 01/16/2024 01/17/2024
DeSchuytner Brian

SVP, COO & CFO

Sell 9,327 @ $2.71 $25,276 54,511 01/16/2024 01/17/2024
Bala Mohan

SVP, Chief Development Officer

Sell 3,431 @ $2.71 $9,298 14,052 01/16/2024 01/17/2024
Bala Mohan

SVP, Chief Development Officer

Sell 1,912 @ $1.13 $2,161 8,733 10/26/2023 10/27/2023
MISRA TUSHAR

SVP, Chief Manuf. Officer

Sell 1,908 @ $1.18 $2,251 11,507 08/17/2023 08/18/2023

Mersana Therapeutics, Inc. Frequently Asked Questions

  • Who is on Mersana Therapeutics, Inc.'s Insider Roster?

    The list of insiders at Mersana Therapeutics, Inc. includes Bala Mohan, DeSchuytner Brian, Carvajal Alejandra, Lowinger Timothy B, Mandelia Ashish, MISRA TUSHAR, Protopapas Anna, Huber Martin H. Jr..

  • How much insider selling is happening at Mersana Therapeutics, Inc.?

    Insiders have sold a total of 178,716 Mersana Therapeutics, Inc. shares in the last 12 months for a total of 390,684 sold.

  • Which Mersana Therapeutics, Inc. insiders have been selling company stock?

    The following insiders have sold Mersana Therapeutics, Inc. shares in the last 12 months: Bala Mohan ($36,448), DeSchuytner Brian ($52,426), Carvajal Alejandra ($39,023), Lowinger Timothy B ($55,358), Mandelia Ashish ($29,915), MISRA TUSHAR ($9,097), Protopapas Anna ($79,671), Huber Martin H. Jr. ($88,744),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.